United Therapeutics (UTHR) Insider Trading & Ownership $568.43 0.00 (0.00%) Closing price 05/22/2026 04:00 PM EasternExtended Trading$568.09 -0.34 (-0.06%) As of 05/22/2026 05:36 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock United Therapeutics (NASDAQ:UTHR) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage8.60%Number OfInsiders Buying(Last 12 Months)0Number OfInsiders Selling(Last 12 Months)13Amount OfInsider Selling(Last 12 Months)$790.56M Get UTHR Insider Trade Alerts Want to know when executives and insiders are buying or selling United Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Subscribe Now View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. UTHR Insider Buying and Selling by Quarter United Therapeutics Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame Start Date End Date Export Transaction DateInsiderBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails5/21/2026James EdgemondCFOSell10,000$564.11$5,641,100.00 5/21/2026Paul A MahonEVPSell8,300$562.82$4,671,406.00 5/20/2026Martine A RothblattCEOSell9,500$565.98$5,376,810.00 5/18/2026James EdgemondCFOSell10,000$567.31$5,673,100.00 5/18/2026Martine A RothblattCEOSell9,500$567.04$5,386,880.00 5/15/2026Martine A RothblattCEOSell9,500$568.11$5,397,045.00 5/14/2026James EdgemondCFOSell10,000$574.47$5,744,700.00 5/13/2026Martine A RothblattCEOSell9,500$578.65$5,497,175.00 5/12/2026Nilda MesaDirectorSell258$581.93$150,137.94 5/11/2026James EdgemondCFOSell10,000$573.03$5,730,300.00 Get Insider Trades Delivered To Your InboxEnter your email address below to receive a concise daily summary of insider buying activity, insider selling activity and changes in hedge fund holdings. 5/11/2026Martine A RothblattCEOSell9,500$573.10$5,444,450.00 5/8/2026Martine A RothblattCEOSell9,500$564.95$5,367,025.00 5/7/2026James EdgemondCFOSell10,000$578.58$5,785,800.00 5/7/2026Paul A MahonEVPSell8,300$586.75$4,870,025.00 5/6/2026Martine A RothblattCEOSell9,500$589.52$5,600,440.00 5/4/2026James EdgemondCFOSell10,000$576.93$5,769,300.00 5/4/2026Martine A RothblattCEOSell9,500$576.97$5,481,215.00 5/1/2026Martine A RothblattCEOSell9,500$570.58$5,420,510.00 4/30/2026James EdgemondCFOSell10,000$572.61$5,726,100.00 4/29/2026Martine A RothblattCEOSell9,500$571.22$5,426,590.00 4/27/2026James EdgemondCFOSell10,000$568.83$5,688,300.00 4/27/2026Martine A RothblattCEOSell9,500$568.81$5,403,695.00 4/24/2026Christopher PatuskyDirectorSell2,910$569.00$1,655,790.00 4/24/2026Martine A RothblattCEOSell9,500$564.81$5,365,695.00 4/23/2026James EdgemondCFOSell9,636$572.21$5,513,815.56 4/22/2026James EdgemondCFOSell364$575.85$209,609.40 4/22/2026Martine A RothblattCEOSell9,500$576.56$5,477,320.00 4/20/2026James EdgemondCFOSell10,000$577.86$5,778,600.00 4/20/2026Martine A RothblattCEOSell9,500$577.83$5,489,385.00 4/17/2026Christopher PatuskyDirectorSell1,000$578.88$578,880.00 4/17/2026Martine A RothblattCEOSell9,500$586.66$5,573,270.00 4/16/2026James EdgemondCFOSell10,000$577.18$5,771,800.00 4/16/2026Paul A MahonEVPSell8,300$576.82$4,787,606.00 4/15/2026Martine A RothblattCEOSell9,500$580.36$5,513,420.00 4/13/2026James EdgemondCFOSell10,000$574.88$5,748,800.00 4/13/2026Martine A RothblattCEOSell9,500$574.86$5,461,170.00 4/10/2026Martine A RothblattCEOSell9,500$569.28$5,408,160.00 4/9/2026James EdgemondCFOSell10,000$577.89$5,778,900.00 4/8/2026Martine A RothblattCEOSell9,500$580.45$5,514,275.00 4/6/2026James EdgemondCFOSell10,000$558.40$5,584,000.00 Nobody Understands Why Trump Is Invading Iran (here’s the answer) (Ad)Most investors are reacting to the Iran strikes without understanding the underlying motive driving the decision. Addison Wiggin, Founder of Grey Swan Investment Fraternity, says there is a hidden reason behind the bombing - and knowing it could change how you position your money right now.Discover the real reason behind the Iran strikes before markets react4/6/2026Martine A RothblattCEOSell9,500$558.41$5,304,895.00 4/2/2026James EdgemondCFOSell10,000$561.50$5,615,000.00 4/2/2026Paul A MahonEVPSell8,300$565.87$4,696,721.00 4/1/2026Martine A RothblattCEOSell9,500$581.63$5,525,485.00 3/30/2026James EdgemondCFOSell10,000$593.17$5,931,700.00 3/30/2026Martine A RothblattCEOSell9,500$590.59$5,610,605.00 3/26/2026James EdgemondCFOSell10,000$535.90$5,359,000.00 3/26/2026Martine A RothblattCEOSell9,500$535.81$5,090,195.00 3/23/2026James EdgemondCFOSell10,000$527.48$5,274,800.00 3/23/2026Martine A RothblattCEOSell9,500$527.01$5,006,595.00 3/20/2026Martine A RothblattCEOSell9,500$524.99$4,987,405.00 3/19/2026Paul A MahonEVPSell8,300$529.95$4,398,585.00 3/18/2026Martine A RothblattCEOSell9,500$529.59$5,031,105.00 3/16/2026Martine A RothblattCEOSell516$534.99$276,054.84 3/16/2026Martine A RothblattCEOSell9,500$533.90$5,072,050.00 3/13/2026Martine A RothblattCEOSell9,500$538.00$5,111,000.00 3/13/2026Martine A RothblattCEOSell75$536.95$40,271.25 3/12/2026Martine A RothblattCEOSell8,984$537.97$4,833,122.48 3/11/2026Martine A RothblattCEOSell9,500$539.54$5,125,630.00 3/9/2026Martine A RothblattCEOSell9,500$518.03$4,921,285.00 3/6/2026Martine A RothblattCEOSell9,500$477.67$4,537,865.00 3/5/2026Paul A MahonEVPSell8,300$483.16$4,010,228.00 3/4/2026Christopher CauseyDirectorSell20$490.17$9,803.40 3/4/2026Martine A RothblattCEOSell9,500$489.91$4,654,145.00 3/4/2026Ray KurzweilDirectorSell4,910$489.02$2,401,088.20 3/4/2026Tommy G ThompsonDirectorSell2,000$489.42$978,840.00 2/25/2026Christopher CauseyDirectorSell1,000$520.00$520,000.00 2/23/2026Michael BenkowitzCOOSell14,440$472.13$6,817,557.20 2/19/2026Paul A MahonEVPSell8,300$476.34$3,953,622.00 2/9/2026Michael BenkowitzCOOSell22,500$474.65$10,679,625.00 2/5/2026Paul A MahonEVPSell8,300$483.25$4,010,975.00 2/3/2026Jan MalcolmDirectorSell50$474.23$23,711.50 2/2/2026Michael BenkowitzCOOSell22,500$470.95$10,596,375.00 1/26/2026Michael BenkowitzCOOSell22,500$471.91$10,617,975.00 1/20/2026Michael BenkowitzCOOSell7,875$464.66$3,659,197.50 1/20/2026Michael BenkowitzCOOSell14,625$464.66$6,795,652.50 1/16/2026Jan MalcolmDirectorSell50$460.98$23,049.00 1/15/2026Paul A MahonEVPSell8,300$469.89$3,900,087.00 1/12/2026Michael BenkowitzCOOSell22,500$479.51$10,788,975.00 1/6/2026Christopher CauseyDirectorSell1,000$510.00$510,000.00 1/5/2026Jan MalcolmDirectorSell50$495.01$24,750.50 1/5/2026Michael BenkowitzCOOSell14,625$487.38$7,127,932.50 1/5/2026Michael BenkowitzCOOSell7,875$487.38$3,838,117.50 1/2/2026Christopher CauseyDirectorSell1,000$500.01$500,010.00 1/2/2026Paul A MahonEVPSell8,300$485.43$4,029,069.00 12/29/2025Michael BenkowitzCOOSell22,500$502.79$11,312,775.00 12/24/2025Paul A MahonEVPSell11,000$513.18$5,644,980.00 12/23/2025Jan MalcolmDirectorSell50$512.12$25,606.00 12/22/2025Louis W SullivanDirectorSell5,950$512.13$3,047,173.50 12/22/2025Michael BenkowitzCOOSell22,500$514.35$11,572,875.00 The Iran War Just Broke the Gold Market (Ad)The Iran war isn't just a geopolitical event. It's a financial one. Within hours of the strikes, oil surged… Defense stocks exploded…And gold ripped past $5,000.You can see the evidence — and the ticker symbol — here >>>12/19/2025Martine A RothblattCEOSell2,000$507.07$1,014,140.00 12/18/2025Tommy G ThompsonDirectorSell910$500.59$455,536.90 12/17/2025Martine A RothblattCEOSell4,000$501.04$2,004,160.00 12/15/2025Christopher PatuskyDirectorSell1,000$495.95$495,950.00 12/15/2025James EdgemondCFOSell3,517$495.36$1,742,181.12 12/15/2025Martine A RothblattCEOSell4,000$494.72$1,978,880.00 12/15/2025Michael BenkowitzCOOSell22,500$496.30$11,166,750.00 12/12/2025Martine A RothblattCEOSell4,000$490.70$1,962,800.00 12/11/2025Jan MalcolmDirectorSell50$482.98$24,149.00 12/11/2025Paul A MahonEVPSell11,000$484.67$5,331,370.00 12/10/2025Martine A RothblattCEOSell4,000$480.05$1,920,200.00 12/9/2025Nilda MesaDirectorSell187$481.63$90,064.81 12/8/2025James EdgemondCFOSell21,000$478.60$10,050,600.00 12/8/2025Martine A RothblattCEOSell4,000$484.23$1,936,920.00 12/8/2025Michael BenkowitzCOOSell22,500$478.58$10,768,050.00 12/5/2025Martine A RothblattCEOSell4,000$483.28$1,933,120.00 12/3/2025Martine A RothblattCEOSell4,000$475.27$1,901,080.00 12/1/2025James EdgemondCFOSell21,000$479.99$10,079,790.00 12/1/2025Martine A RothblattCEOSell4,000$481.93$1,927,720.00 12/1/2025Michael BenkowitzCOOSell22,500$479.91$10,797,975.00 11/28/2025Martine A RothblattCEOSell4,000$487.64$1,950,560.00 11/26/2025Paul A MahonEVPSell11,000$486.06$5,346,660.00 11/25/2025Martine A RothblattCEOSell4,000$475.33$1,901,320.00 11/24/2025James EdgemondCFOSell21,000$473.64$9,946,440.00 11/24/2025Michael BenkowitzCOOSell22,500$473.66$10,657,350.00 11/21/2025Martine A RothblattCEOSell4,000$474.64$1,898,560.00 11/19/2025Martine A RothblattCEOSell4,000$474.58$1,898,320.00 11/17/2025James EdgemondCFOSell21,000$470.36$9,877,560.00 11/17/2025Martine A RothblattCEOSell4,000$467.55$1,870,200.00 11/17/2025Michael BenkowitzCOOSell22,500$470.43$10,584,675.00 11/14/2025Martine A RothblattCEOSell4,000$462.94$1,851,760.00 11/13/2025Paul A MahonEVPSell11,000$464.76$5,112,360.00 11/12/2025Martine A RothblattCEOSell4,000$460.00$1,840,000.00 11/10/2025James EdgemondCFOSell21,000$452.07$9,493,470.00 11/10/2025Michael BenkowitzCOOSell22,500$452.07$10,171,575.00 11/7/2025Martine A RothblattCEOSell4,000$448.25$1,793,000.00 11/5/2025Martine A RothblattCEOSell4,000$437.98$1,751,920.00 11/4/2025James EdgemondCFOSell21,000$436.09$9,157,890.00 11/3/2025Martine A RothblattCEOSell4,000$438.30$1,753,200.00 11/3/2025Michael BenkowitzCOOSell22,500$429.25$9,658,125.00 10/31/2025Lisa C. McClainHouse (R-MI)Sell$445.43$1,001 - $15,00010/30/2025Martine A RothblattCEOSell4,000$448.96$1,795,840.00 10/30/2025Paul A MahonEVPSell11,000$450.34$4,953,740.00 10/30/2025Lisa C. McClainHouse (R-MI)Sell$453.53$1,001 - $15,00010/30/2025Lisa C. McClainHouse (R-MI)Buy$453.53$1,001 - $15,00010/27/2025Martine A RothblattCEOSell4,000$415.54$1,662,160.00 10/27/2025Michael BenkowitzCOOSell22,500$417.50$9,393,750.00 10/27/2025Michael T. McCaulHouse (R-TX)Sell$421.04$15,001 - $50,00010/24/2025Martine A RothblattCEOSell4,000$424.06$1,696,240.00 10/22/2025Martine A RothblattCEOSell4,000$422.15$1,688,600.00 10/20/2025Martine A RothblattCEOSell4,000$424.59$1,698,360.00 10/20/2025Michael BenkowitzCOOSell22,500$427.41$9,616,725.00 10/16/2025Martine A RothblattCEOSell4,000$431.31$1,725,240.00 10/16/2025Paul A MahonEVPSell11,000$431.50$4,746,500.00 Louis Navellier: My #1 AI stock for 2026 (name & ticker inside) (Ad)Louis Navellier's Stock Grader system helped him flag Nvidia before its 82,000% run and has identified the top S&P 500 stock for 12 years running—and today, he's giving away his #1 AI stock pick for 2026, free. This company's sales are up 28% year over year, it holds over 30,000 patents in wireless and video technology, and it just earned an A-rating in his proprietary Stock Grader system that has cost him $9 million to build and maintain.Get the name and ticker of Louis Navellier's #1 AI stock free10/13/2025Martine A RothblattCEOSell4,000$440.43$1,761,720.00 10/13/2025Michael BenkowitzCOOSell22,500$440.35$9,907,875.00 10/10/2025Martine A RothblattCEOSell4,000$444.70$1,778,800.00 10/8/2025Martine A RothblattCEOSell4,000$450.86$1,803,440.00 10/6/2025Martine A RothblattCEOSell4,000$449.69$1,798,760.00 10/6/2025Michael BenkowitzCOOSell22,500$450.24$10,130,400.00 10/2/2025Martine A RothblattCEOSell4,000$434.88$1,739,520.00 10/2/2025Paul A MahonEVPSell11,000$436.60$4,802,600.00 9/29/2025Martine A RothblattCEOSell4,000$425.63$1,702,520.00 9/29/2025Michael BenkowitzCOOSell22,500$421.80$9,490,500.00 9/26/2025Martine A RothblattCEOSell4,000$428.22$1,712,880.00 9/24/2025Christopher CauseyDirectorSell1,000$440.00$440,000.00 9/24/2025Martine A RothblattCEOSell4,000$434.12$1,736,480.00 9/22/2025Martine A RothblattCEOSell4,000$417.30$1,669,200.00 9/22/2025Michael BenkowitzCOOSell22,500$416.35$9,367,875.00 9/19/2025Judy D OlianDirectorSell1,800$415.43$747,774.00 9/19/2025Martine A RothblattCEOSell4,000$411.08$1,644,320.00 9/18/2025Paul A MahonEVPSell11,000$406.17$4,467,870.00 9/17/2025Martine A RothblattCEOSell4,000$400.17$1,600,680.00 9/15/2025Martine A RothblattCEOSell4,000$397.88$1,591,520.00 9/15/2025Michael BenkowitzCOOSell22,500$400.56$9,012,600.00 9/11/2025Martine A RothblattCEOSell4,000$397.23$1,588,920.00 9/10/2025Tommy G ThompsonDirectorSell4,560$403.36$1,839,321.60 9/9/2025Jan MalcolmDirectorSell700$400.29$280,203.00 9/9/2025Martine A RothblattCEOSell8,000$398.55$3,188,400.00 9/9/2025Michael BenkowitzCOOSell11,375$397.41$4,520,538.75 9/8/2025Michael BenkowitzCOOSell5,000$392.21$1,961,050.00 9/4/2025Paul A MahonEVPSell11,000$385.21$4,237,310.00 9/2/2025Christopher CauseyDirectorSell3,000$423.21$1,269,630.00 9/2/2025Michael BenkowitzCOOSell22,500$417.64$9,396,900.00 8/22/2025Michael T. McCaulHouse (R-TX)Sell$312.23$50,001 - $100,0008/21/2025Paul A MahonEVPSell11,000$308.75$3,396,250.00 8/7/2025Paul A MahonEVPSell11,000$300.00$3,300,000.00 8/7/2025Michael T. McCaulHouse (R-TX)Buy$299.42$50,001 - $100,0007/24/2025Paul A MahonEVPSell11,000$304.11$3,345,210.00 7/10/2025Paul A MahonEVPSell11,000$300.31$3,303,410.00 6/27/2025Michael T. McCaulHouse (R-TX)Sell$284.27$100,001 - $250,0006/26/2025Paul A MahonEVPSell11,000$285.70$3,142,700.00 6/24/2025Nilda MesaDirectorSell645$289.99$187,043.55 6/24/2025Richard GiltnerDirectorSell3,036$289.60$879,225.60 6/12/2025Paul A MahonEVPSell11,000$279.96$3,079,560.00 6/11/2025Lisa C. McClainHouse (R-MI)Buy$276.47$1,001 - $15,0006/9/2025James EdgemondCFOSell12,000$325.37$3,904,440.00 5/29/2025Paul A MahonEVPSell11,000$316.07$3,476,770.00 (Data available from 1/1/2013 forward) UTHR Insider Trading Activity - Frequently Asked Questions Who is on United Therapeutics' Insider Roster? The list of insiders at United Therapeutics includes Christopher Causey, Christopher Patusky, James Edgemond, Jan Malcolm, Judy D Olian, Louis W Sullivan, Martine A Rothblatt, Michael Benkowitz, Nilda Mesa, Paul A Mahon, Ray Kurzweil, Raymond Dwek, Richard Giltner, and Tommy G Thompson. Learn more on insiders at UTHR. What percentage of United Therapeutics stock is owned by insiders? 8.60% of United Therapeutics stock is owned by insiders. Learn more on UTHR's insider holdings. Which United Therapeutics insiders have been selling company stock? The following insiders have sold UTHR shares in the last 24 months: Christopher Causey ($4,004,584.70), Christopher Patusky ($2,730,620.00), James Edgemond ($188,777,510.13), Jan Malcolm ($401,469.00), Judy D Olian ($1,469,614.00), Louis W Sullivan ($12,828,896.48), Martine A Rothblatt ($273,742,948.86), Michael Benkowitz ($312,381,532.95), Nilda Mesa ($695,060.65), Paul A Mahon ($126,526,725.00), Ray Kurzweil ($2,401,088.20), Raymond Dwek ($4,477,140.00), Richard Giltner ($879,225.60), and Tommy G Thompson ($4,070,698.50). How much insider selling is happening at United Therapeutics? Insiders have sold a total of 2,056,969 United Therapeutics shares in the last 24 months for a total of $935,387,114.07 sold. Which members of congress are trading United Therapeutics? Lisa C. McClain (R-MI) and Michael T. McCaul (R-TX) have bought shares of United Therapeutics in the last year totaling $91,000. Lisa C. McClain (R-MI) and Michael T. McCaul (R-TX) have sold shares totaling $298,500. United Therapeutics Active InsidersMartine A Rothblatt (Age 71)CEO45 recent tradesMichael BenkowitzCOO14 recent tradesJames EdgemondCFO22 recent tradesChristopher PatuskyDirector7 recent tradesChristopher CauseyDirector7 recent tradesJudy D OlianDirectorRaymond DwekDirectorNilda MesaDirector2 recent tradesLouis W SullivanDirector1 recent tradesTommy G ThompsonDirector2 recent tradesRichard GiltnerDirectorJan MalcolmDirector5 recent tradesRay KurzweilDirector1 recent tradesPaul A Mahon (Age 62)EVP13 recent trades More Insider Trading Tools from MarketBeat Related Companies REGN Insider Selling ALNY Insider Selling BIIB Insider Selling INCY Insider Selling NBIX Insider Selling EXEL Insider Selling IONS Insider Selling MDGL Insider Selling BMRN Insider Selling HALO Insider Selling Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Latest Articles 3 Dividend Stocks With Insiders Buying in 2026Insider Buying Says Upstart Isn’t Down for the CountInsider Trades: Okta and Abbott See Buys, Micron Insiders SellMarketBeat Week in Review – 05/04 - 05/08BlackBerry Rewrites Its Own Operating System This page (NASDAQ:UTHR) was last updated on 5/25/2026 by MarketBeat.com Staff. From Our PartnersSpaceX eyes a 1.75 trillion valuation - here's what to knowElon Musk's team has quietly filed confidential paperwork with the SEC for what Bloomberg estimates could be a...Brownstone Research | Sponsored$30 stock to buy before Starlink goes public (WATCH NOW!)In the next 3 minutes… James Altucher – legendary investor and venture capitalist… And someone who’s kno...Paradigm Press | SponsoredYour book attachedBill Poulos is giving away his 'Safe Trade Options Formula' book for free - but only for a limited time throug...Profits Run | SponsoredMy feud with Zohran MamdaniEmmy-winning analyst releases his next big story Whitney Tilson shocked the nation on 60 Minutes when he ac...Stansberry Research | SponsoredSpaceX IPO hides a much bigger storyThe SpaceX IPO could be the biggest in history at $1.75 trillion - but the real story isn't the IPO itself. ...Weiss Ratings | SponsoredRead now. Do not delete. You’ve been warned.Three Nobel Prize Winners expose this once-in-a-generation wealth shift: “Don’t Say I Didn’t Warn You” P...Porter & Company | SponsoredSatellite Images Spot Potential $10 Trillion Discovery'Dark Energy': Elon Musk's Next Potential $10 Trillion Move A highly secure site in West Texas now houses a...Altimetry | SponsoredSpaceX will mint billionaires. You won't be one of them.By the time a company goes public, 95% of profits have already been made. Insiders bought SpaceX at $20 billio...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding United Therapeutics Corporation Please log in to your account or sign up in order to add this asset to your watchlist. Share United Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
